Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-090469
Filing Date
2020-08-04
Accepted
2020-08-04 21:02:23
Documents
1
Period of Report
2020-08-03

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4161
  Complete submission text file 0001104659-20-090469.txt   5792
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BROCK HOUSE, SHEEPDROVE LAMBOURN HUNGERFORD, BERKS X0 RG17 7XA
Business Address
TAYTON-MARTIN HELEN KATRINA (Reporting) CIK: 0001661780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 201075336